ABVC BioPharma to acquire a real estate worth of $2.96M in Taiwan
ABVC BioPharma to acquire a real estate worth of $2.96M in Taiwan
31.25MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00091F1066
CUSIP
00091F106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.37
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.19
Wall Street Target Price
2.02
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
508,384
Gross Profit TTM
507,898
EBITDA
-2,522,232
Profit Margin
0.00%
Return On Assets TTM
-10.91%
Return On Equity TTM
-42.42%
Revenue Per Share TTM
0.039
Qtly Revenue Growth YOY
-9.20%
Diluted Eps TTM
-0.19
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
61.4617
Price Book MRQ
5.9073
Enterprise Value Revenue
66
Enterprise Value EBITDA
-1
95.50
5.58%257.51
4.39%193.85
2.60%313.25
1.13%445.00
0.94%78.39
0.69%512.58
0.66%586.54
0.00%148.56
0.00%540.76
-0.27%